Cargando…

Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium

Detalles Bibliográficos
Autores principales: Dessilly, Géraldine, Goeminne, Léonie, Vandenbroucke, Anne-thérèse, Dufrasne, François E., Martin, Anandi, Kabamba-Mukadi, Benoît
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347154/
https://www.ncbi.nlm.nih.gov/pubmed/30682153
http://dx.doi.org/10.1371/journal.pone.0211587
_version_ 1783389885733797888
author Dessilly, Géraldine
Goeminne, Léonie
Vandenbroucke, Anne-thérèse
Dufrasne, François E.
Martin, Anandi
Kabamba-Mukadi, Benoît
author_facet Dessilly, Géraldine
Goeminne, Léonie
Vandenbroucke, Anne-thérèse
Dufrasne, François E.
Martin, Anandi
Kabamba-Mukadi, Benoît
author_sort Dessilly, Géraldine
collection PubMed
description
format Online
Article
Text
id pubmed-6347154
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63471542019-02-02 Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium Dessilly, Géraldine Goeminne, Léonie Vandenbroucke, Anne-thérèse Dufrasne, François E. Martin, Anandi Kabamba-Mukadi, Benoît PLoS One Correction Public Library of Science 2019-01-25 /pmc/articles/PMC6347154/ /pubmed/30682153 http://dx.doi.org/10.1371/journal.pone.0211587 Text en © 2019 Dessilly et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Dessilly, Géraldine
Goeminne, Léonie
Vandenbroucke, Anne-thérèse
Dufrasne, François E.
Martin, Anandi
Kabamba-Mukadi, Benoît
Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title_full Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title_fullStr Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title_full_unstemmed Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title_short Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
title_sort correction: first evaluation of the next-generation sequencing platform for the detection of hiv-1 drug resistance mutations in belgium
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347154/
https://www.ncbi.nlm.nih.gov/pubmed/30682153
http://dx.doi.org/10.1371/journal.pone.0211587
work_keys_str_mv AT dessillygeraldine correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium
AT goeminneleonie correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium
AT vandenbrouckeannetherese correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium
AT dufrasnefrancoise correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium
AT martinanandi correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium
AT kabambamukadibenoit correctionfirstevaluationofthenextgenerationsequencingplatformforthedetectionofhiv1drugresistancemutationsinbelgium